319 related articles for article (PubMed ID: 32753022)
21. Human papilloma virus 16 E6 RNA interference enhances cisplatin and death receptor-mediated apoptosis in human cervical carcinoma cells.
Tan S; Hougardy BM; Meersma GJ; Schaap B; de Vries EG; van der Zee AG; de Jong S
Mol Pharmacol; 2012 May; 81(5):701-9. PubMed ID: 22328720
[TBL] [Abstract][Full Text] [Related]
22. Antitumor activity of new combination chemotherapy with irinotecan hydrochloride and nedaplatin against human cervical cancer cell lines.
Yamamoto K; Iwahana M; Kumazawa E; Kakihata K; Abe K; Hirano F; Tohgo A; Hoshiai H; Noda K
Oncol Rep; 2003; 10(3):593-8. PubMed ID: 12684629
[TBL] [Abstract][Full Text] [Related]
23. Honeybee venom possesses anticancer and antiviral effects by differential inhibition of HPV E6 and E7 expression on cervical cancer cell line.
Kim YW; Chaturvedi PK; Chun SN; Lee YG; Ahn WS
Oncol Rep; 2015 Apr; 33(4):1675-82. PubMed ID: 25633640
[TBL] [Abstract][Full Text] [Related]
24. Discovery of 2-(2-aminobenzo[d]thiazol-6-yl) benzo[d]oxazol-5-amine derivatives that regulated HPV relevant cellular pathway and prevented cervical cancer from abnormal proliferation.
Jiao P; Wang Y; Mao B; Wang B; Zhong Y; Jin H; Zhang L; Zhang L; Liu Z
Eur J Med Chem; 2020 Oct; 204():112556. PubMed ID: 32739649
[TBL] [Abstract][Full Text] [Related]
25. Diallyl trisulfide suppresses tumor growth through the attenuation of Nrf2/Akt and activation of p38/JNK and potentiates cisplatin efficacy in gastric cancer treatment.
Jiang XY; Zhu XS; Xu HY; Zhao ZX; Li SY; Li SZ; Cai JH; Cao JM
Acta Pharmacol Sin; 2017 Jul; 38(7):1048-1058. PubMed ID: 28344324
[TBL] [Abstract][Full Text] [Related]
26. Effects of Quercetin on the Efficacy of Various Chemotherapeutic Drugs in Cervical Cancer Cells.
Xu W; Xie S; Chen X; Pan S; Qian H; Zhu X
Drug Des Devel Ther; 2021; 15():577-588. PubMed ID: 33623367
[TBL] [Abstract][Full Text] [Related]
27. Human Papillomavirus E6/E7-Specific siRNA Potentiates the Effect of Radiotherapy for Cervical Cancer in Vitro and in Vivo.
Jung HS; Rajasekaran N; Song SY; Kim YD; Hong S; Choi HJ; Kim YS; Choi JS; Choi YL; Shin YK
Int J Mol Sci; 2015 May; 16(6):12243-60. PubMed ID: 26035754
[TBL] [Abstract][Full Text] [Related]
28. Antisense targeting human papillomavirus type 16 E6 and E7 genes contributes to apoptosis and senescence in SiHa cervical carcinoma cells.
Sima N; Wang S; Wang W; Kong D; Xu Q; Tian X; Luo A; Zhou J; Xu G; Meng L; Lu Y; Ma D
Gynecol Oncol; 2007 Aug; 106(2):299-304. PubMed ID: 17586029
[TBL] [Abstract][Full Text] [Related]
29. The combinational effect of E6/E7 siRNA and anti-miR-182 on apoptosis induction in HPV16-positive cervical cells.
Javadi H; Lotfi AS; Hosseinkhani S; Mehrani H; Amani J; Soheili ZS; Hojati Z; Kamali M
Artif Cells Nanomed Biotechnol; 2018; 46(sup2):727-736. PubMed ID: 29873516
[TBL] [Abstract][Full Text] [Related]
30. Mifepristone sensitizing cisplatin for cervical adenocarcinoma HeLa cell sensitivity to chemotherapy and its mechanism.
Li C; Ye H
Eur J Gynaecol Oncol; 2013; 34(2):142-7. PubMed ID: 23781585
[TBL] [Abstract][Full Text] [Related]
31. A novel HPV16 E7-affitoxin for targeted therapy of HPV16-induced human cervical cancer.
Jiang P; Wang L; Hou B; Zhu J; Zhou M; Jiang J; Wang L; Chen S; Zhu S; Chen J; Zhang L
Theranostics; 2018; 8(13):3544-3558. PubMed ID: 30026865
[TBL] [Abstract][Full Text] [Related]
32. In vitro antigene therapy targeting HPV-16 E6 and E7 in cervical carcinoma.
Madrigal M; Janicek MF; Sevin BU; Perras J; Estape R; Peñalver M; Averette HE
Gynecol Oncol; 1997 Jan; 64(1):18-25. PubMed ID: 8995542
[TBL] [Abstract][Full Text] [Related]
33. Eradication of cervical cancer in vivo by an AAV vector that encodes shRNA targeting human papillomavirus type 16 E6/E7.
Sato N; Saga Y; Uchibori R; Tsukahara T; Urabe M; Kume A; Fujiwara H; Suzuki M; Ozawa K; Mizukami H
Int J Oncol; 2018 Mar; 52(3):687-696. PubMed ID: 29344635
[TBL] [Abstract][Full Text] [Related]
34. Artepillin C Induces Selective Oxidative Stress and Inhibits Migration and Invasion in a Comprehensive Panel of Human Cervical Cancer Cell Lines.
Souza RP; Bonfim-Mendonça PS; Damke GMZF; de-Assis Carvalho ARB; Ratti BA; Dembogurski DSO; da-Silva VRS; Silva SO; Da-Silva DB; Bruschi ML; Maria-Engler SS; Consolaro MEL
Anticancer Agents Med Chem; 2018; 18(12):1750-1760. PubMed ID: 29866020
[TBL] [Abstract][Full Text] [Related]
35. Arsenic trioxide induces cervical cancer apoptosis, but specifically targets human papillomavirus-infected cell populations.
Wen X; Li D; Zhang Y; Liu S; Ghali L; Iles RK
Anticancer Drugs; 2012 Mar; 23(3):280-7. PubMed ID: 22245994
[TBL] [Abstract][Full Text] [Related]
36. Targeting mTOR by CZ415 Suppresses Cell Proliferation and Promotes Apoptosis via Lipin-1 in Cervical Cancer In Vitro and In Vivo.
Zhang J
Reprod Sci; 2021 Feb; 28(2):524-531. PubMed ID: 32944878
[TBL] [Abstract][Full Text] [Related]
37. Oxymatrine induces apoptosis in human cervical cancer cells through guanine nucleotide depletion.
Li M; Su BS; Chang LH; Gao Q; Chen KL; An P; Huang C; Yang J; Li ZF
Anticancer Drugs; 2014 Feb; 25(2):161-73. PubMed ID: 24231526
[TBL] [Abstract][Full Text] [Related]
38. Upregulation of MTA1 expression by human papillomavirus infection promotes CDDP resistance in cervical cancer cells via modulation of NF-κB/APOBEC3B cascade.
Jia QP; Yan CY; Zheng XR; Pan X; Cao X; Cao L
Cancer Chemother Pharmacol; 2019 Apr; 83(4):625-637. PubMed ID: 30631898
[TBL] [Abstract][Full Text] [Related]
39. Synergistic anticancer activity of 5-aminolevulinic acid photodynamic therapy in combination with low-dose cisplatin on Hela cells.
Wei XQ; Ma HQ; Liu AH; Zhang YZ
Asian Pac J Cancer Prev; 2013; 14(5):3023-8. PubMed ID: 23803073
[TBL] [Abstract][Full Text] [Related]
40. LncRNA KCNQ1OT1 contributes to the cisplatin resistance of tongue cancer through the KCNQ1OT1/miR-124-3p/TRIM14 axis.
Qiao CY; Qiao TY; Jin H; Liu LL; Zheng MD; Wang ZL
Eur Rev Med Pharmacol Sci; 2020 Jan; 24(1):200-212. PubMed ID: 31957833
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
